The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J06 | Immune sera and immunoglobulins | |
| 3 | J06B | Immunoglobulins | |
| 4 | J06BB | Specific immunoglobulins | |
| 5 | J06BB02 | Tetanus immunoglobulin |
| Active Ingredient | Description | |
|---|---|---|
| Tetanus immunoglobulin |
Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| HYPERTET Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| TETAGAM-P Solution for injection | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
